AP2408A - Pyridine[3,4-B]pyrazinones. - Google Patents

Pyridine[3,4-B]pyrazinones.

Info

Publication number: AP2408A
Authority: AP; ARIPO
Prior art keywords: pyrazinones; pyridine
Prior art date: 2006-04-21

Application number

AP2008004640A

Other languages

English (en)

Other versions

AP2008004640A0 (en

Inventor

Andrew Simon Bell

David Louis Brown

David Graham Brown

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-21

Filing date

2007-04-10

Publication date

2012-05-30

2007-04-10 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2008-10-31 Publication of AP2008004640A0 publication Critical patent/AP2008004640A0/xx

2012-05-30 Application granted granted Critical

2012-05-30 Publication of AP2408A publication Critical patent/AP2408A/xx

Links

JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Separation Of Suspended Particles By Flocculating Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Epoxy Compounds (AREA)

AP2008004640A 2006-04-21 2007-04-10 Pyridine[3,4-B]pyrazinones. AP2408A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US79397106P	2006-04-21	2006-04-21
PCT/IB2007/001001 WO2007122466A1 (fr)	2006-04-21	2007-04-10	Pyridine[3,4-b]pyrazinones

Publications (2)

Publication Number	Publication Date
AP2008004640A0 AP2008004640A0 (en)	2008-10-31
AP2408A true AP2408A (en)	2012-05-30

Family

ID=38431249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2008004640A AP2408A (en)	2006-04-21	2007-04-10	Pyridine[3,4-B]pyrazinones.

Country Status (41)

Country	Link
US (1)	US7902195B2 (fr)
EP (1)	EP2013208B1 (fr)
JP (1)	JP4436892B2 (fr)
KR (1)	KR101061328B1 (fr)
CN (1)	CN101454320B (fr)
AP (1)	AP2408A (fr)
AR (1)	AR060525A1 (fr)
AT (1)	ATE513831T1 (fr)
AU (1)	AU2007242555B2 (fr)
BR (1)	BRPI0710658A2 (fr)
CA (1)	CA2649775C (fr)
CR (1)	CR10327A (fr)
CU (1)	CU23777B7 (fr)
CY (1)	CY1111739T1 (fr)
DK (1)	DK2013208T3 (fr)
DO (1)	DOP2007000080A (fr)
EA (1)	EA014919B1 (fr)
EC (1)	ECSP088803A (fr)
ES (1)	ES2366239T3 (fr)
GT (1)	GT200700035A (fr)
HR (1)	HRP20110539T1 (fr)
IL (1)	IL194591A (fr)
MA (1)	MA30352B1 (fr)
ME (1)	MEP23808A (fr)
MX (1)	MX2008012456A (fr)
MY (1)	MY148583A (fr)
NL (1)	NL2000583C2 (fr)
NO (1)	NO20084129L (fr)
NZ (1)	NZ571540A (fr)
PA (1)	PA8724201A1 (fr)
PE (1)	PE20080192A1 (fr)
PL (1)	PL2013208T3 (fr)
RS (2)	RS51885B (fr)
SI (1)	SI2013208T1 (fr)
SV (1)	SV2008003074A (fr)
TN (1)	TNSN08408A1 (fr)
TW (1)	TWI337609B (fr)
UA (1)	UA92637C2 (fr)
UY (1)	UY30291A1 (fr)
WO (1)	WO2007122466A1 (fr)
ZA (1)	ZA200808283B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101454320B (zh)	2006-04-21	2012-12-19	辉瑞产品公司	吡啶并[3，4-b]吡嗪酮
SI2101777T1 (sl)	2006-12-12	2015-08-31	Gilead Sciences, Inc.	Sestavek za zdravljenje pljučne hipertenzije
CA2718402C (fr)	2008-03-05	2017-08-22	Merck Patent Gmbh	Derives de pyridopyrazinone comme stimulateurs de la secretion d'insuline, leurs procedes d'obtention et leur utilisation pour le traitement du diabete
WO2010041711A1 (fr) *	2008-10-09	2010-04-15	杏林製薬株式会社	Dérivé d'isoquinoléine et inhibiteur de la pde le comportant en tant qu’ingrédient actif
KR20120091240A (ko) *	2009-10-26	2012-08-17	시그날 파마소티칼 엘엘씨	헤테로아릴 화합물의 합성 및 정제 방법
JP5806320B2 (ja)	2010-10-15	2015-11-10	ギリアードサイエンシーズ，インコーポレイテッド	肺高血圧症を処置するための組成物および方法
JP5767393B2 (ja)	2011-03-31	2015-08-19	ファイザー・インク	新規二環式ピリジノン
WO2012172449A1 (fr)	2011-06-13	2012-12-20	Pfizer Inc.	Lactames convenant comme inhibiteurs des bêta-sécrétases
WO2013030713A1 (fr)	2011-08-31	2013-03-07	Pfizer Inc.	Hexahydropyrano[3,4-d][1,3]thiazine-2-amines
JP6110937B2 (ja)	2012-05-04	2017-04-05	ファイザー・インク	ＡＰＰ、ＢＡＣＥ１、およびＢＡＣＥ２の阻害剤としての複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
CA2882389A1 (fr)	2012-09-20	2014-03-27	Pfizer Inc.	Composes d'hexahydropyrano[3,4-d][1,3]thiazine-2-amine alkyl-substitues
UA110688C2 (uk)	2012-09-21	2016-01-25	Пфайзер Інк.	Біциклічні піридинони
JP2016502978A (ja)	2012-12-11	2016-02-01	ファイザー・インク	ＢＡＣＥ１の阻害剤としてのヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
CA2893333C (fr)	2012-12-19	2017-10-24	Pfizer Inc.	Composes hexahydropyrano[3,4-d][1,3]thiazin-2-amine substitues carbocycliques et heterocycliques
CA2897678A1 (fr)	2013-02-13	2014-08-21	Pfizer Inc.	Composes hexahydropyrano [3,4-d][1,3] thiazin-2-amine substitues par un heteroaryle
US9233981B1 (en)	2013-02-15	2016-01-12	Pfizer Inc.	Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
CA2900302C (fr)	2013-02-19	2018-07-03	Pfizer Inc.	Composes d'azabenzimidazole en tant qu'inhibiteurs d'isozymes pde4 pour le traitement de troubles du snc et d'autres affections
JP6425717B2 (ja)	2013-10-04	2018-11-21	ファイザー・インク	ガンマセクレターゼモジュレーターとしての新規二環式ピリジノン
JO3466B1 (ar) *	2013-12-20	2020-07-05	Takeda Pharmaceuticals Co	مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
EP3126361B1 (fr)	2014-04-01	2019-11-06	Pfizer Inc	Chromène et 1,1a,2,7b-tétrahydrocyclopropa[c]chromène pyridopyrazinediones comme modulateurs de gamma-sécrétase
AU2015245260A1 (en)	2014-04-10	2016-10-06	Pfizer Inc.	2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides
WO2016012896A1 (fr)	2014-07-24	2016-01-28	Pfizer Inc.	Composés de pyrazolopyrimidine
CR20170035A (es)	2014-08-06	2017-04-28	Pfizer	Compuestos de imidazopiridazina
JP6628805B2 (ja)	2015-02-03	2020-01-15	ファイザー・インク	新規シクロプロパベンゾフラニルピリドピラジンジオン
BR112017026191B1 (pt)	2015-06-17	2023-10-10	Pfizer Inc	Compostos tricíclicos inibidores de fosfodiesterase, sua composição farmacêutica e uso dos mesmos
WO2017051294A1 (fr)	2015-09-24	2017-03-30	Pfizer Inc.	N-[2-(3-amino-2,5-diméthyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides utiles comme inhibiteurs de bace
JP2018531924A (ja)	2015-09-24	2018-11-01	ファイザー・インク	テトラヒドロピラノ［３，４−ｄ］［１，３］オキサジン誘導体、およびｂａｃｅ阻害剤としてのその使用
AU2016325665A1 (en)	2015-09-24	2018-03-08	Pfizer Inc.	N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
US10323042B2 (en)	2016-02-23	2019-06-18	Pfizer Inc.	6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
MX386258B (es)	2016-07-01	2025-03-18	Pfizer	Derivados de 5,7-dihidro-pirrolo-piridina para tratar enfermedades neurologicas y neurodegenerativas
PL3642202T3 (pl)	2017-06-22	2023-03-13	Pfizer Inc.	Pochodne dihydropirolopirydyny
MX2019015578A (es) *	2017-06-28	2020-07-28	Ptc Therapeutics Inc	Metodos para tratar la enfermedad de huntington.
CA3094366A1 (fr)	2018-03-23	2019-09-26	Pfizer Inc.	Derives azaspiro de piperazine
WO2022182658A1 (fr)	2021-02-23	2022-09-01	Hoth Therapeutics, Inc.	Utilisation d'aprépitant pour le traitement de la maladie d'alzheimer
WO2024118524A1 (fr)	2022-11-28	2024-06-06	Cerevel Therapeutics, Llc	Composés d'azaindole et leur utilisation en tant qu'inhibiteurs de phosphodiestérase
WO2025145091A1 (fr)	2023-12-29	2025-07-03	Pfizer Inc.	Formes cristallines d'un modulateur muscarinique m4 du récepteur et méthodes de traitement de maladies
WO2025160132A1 (fr) *	2024-01-23	2025-07-31	Maplight Therapeutics, Inc.	Agonistes inverses de gpr6

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020147199A1 (en) *	2000-03-14	2002-10-10	Degenhard Marx	Process for the treatment of erectile dysfunction and product therefor
EP1364950A1 (fr) *	2001-02-26	2003-11-26	Tanabe Seiyaku Co., Ltd.	Derive de pyridopyrimidine ou naphthyridine
WO2006126082A2 (fr) *	2005-05-24	2006-11-30	Pharmacia & Upjohn Company Llc	Pyridine [3,4-b] pyrazinones

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1361652A (fr)	1963-06-21	1964-05-22	Ciba Geigy	Procédé de préparation de diazines, entre autres de la 2-méthyl-6-hydroxy-7-morpholino-ptéridine
CA2095444C (fr)	1990-11-06	2001-06-19	Shuichi Sakamoto	Derives de condensation avec la pyrazine
TW274550B (fr)	1992-09-26	1996-04-21	Hoechst Ag
JP2000154139A (ja)	1998-09-16	2000-06-06	Kyowa Hakko Kogyo Co Ltd	縮環ピラジン誘導体
US6369056B1 (en)	1999-05-04	2002-04-09	American Home Products Corporation	Cyclic urea and cyclic amide derivatives
WO2002076954A1 (fr)	2001-03-23	2002-10-03	Smithkline Beecham Corporation	Composes utiles en tant qu'inhibiteurs de kinase pour le traitement de maladies hyperproliferantes
US20030114469A1 (en) *	2001-09-27	2003-06-19	Cohen David Saul	Combinations
US7067658B2 (en)	2002-09-30	2006-06-27	Bristol-Myers Squibb Company	Pyridino and pyrimidino pyrazinones
JP2007504283A (ja)	2003-05-20	2007-03-01	ザリージェンツオブザユニバーシティオブカリフォルニア	β−アミロイド斑に作用物質を結合させる方法
US7476665B2 (en)	2003-06-26	2009-01-13	Merck & Co., Inc.	Benzodiazepine CGRP receptor antagonists
DE102004033670A1 (de)	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
CA2593005A1 (fr)	2005-01-03	2006-07-13	Myriad Genetics Inc.	Composes pharmaceutiques constituant des activateurs de caspases et des inducteurs d'apoptose et utilisation de ces composes
JP2009509923A (ja)	2005-08-26	2009-03-12	メシルジーン、インコーポレイテッド	ヒストンデアセチラーゼのベンゾジアゼピン及びベンゾピペラジン類似体阻害薬
WO2007112347A1 (fr)	2006-03-28	2007-10-04	Takeda Pharmaceutical Company Limited	Inhibiteurs de la dipeptidyl peptidase
CN101454320B (zh)	2006-04-21	2012-12-19	辉瑞产品公司	吡啶并[3，4-b]吡嗪酮

2007
- 2007-04-10 CN CN2007800198932A patent/CN101454320B/zh not_active Expired - Fee Related
- 2007-04-10 NZ NZ571540A patent/NZ571540A/en not_active IP Right Cessation
- 2007-04-10 HR HR20110539T patent/HRP20110539T1/hr unknown
- 2007-04-10 JP JP2009505983A patent/JP4436892B2/ja not_active Expired - Fee Related
- 2007-04-10 WO PCT/IB2007/001001 patent/WO2007122466A1/fr not_active Ceased
- 2007-04-10 ES ES07734320T patent/ES2366239T3/es active Active
- 2007-04-10 DK DK07734320.0T patent/DK2013208T3/da active
- 2007-04-10 AP AP2008004640A patent/AP2408A/xx active
- 2007-04-10 KR KR1020087028465A patent/KR101061328B1/ko not_active Expired - Fee Related
- 2007-04-10 MX MX2008012456A patent/MX2008012456A/es active IP Right Grant
- 2007-04-10 AU AU2007242555A patent/AU2007242555B2/en not_active Ceased
- 2007-04-10 RS RS20110363A patent/RS51885B/sr unknown
- 2007-04-10 CA CA2649775A patent/CA2649775C/fr not_active Expired - Fee Related
- 2007-04-10 MY MYPI20084131A patent/MY148583A/en unknown
- 2007-04-10 EA EA200801998A patent/EA014919B1/ru not_active IP Right Cessation
- 2007-04-10 SI SI200730675T patent/SI2013208T1/sl unknown
- 2007-04-10 EP EP07734320A patent/EP2013208B1/fr active Active
- 2007-04-10 BR BRPI0710658-0A patent/BRPI0710658A2/pt not_active IP Right Cessation
- 2007-04-10 RS RSP-2008/0484A patent/RS20080484A/sr unknown
- 2007-04-10 ME MEP-238/08A patent/MEP23808A/xx unknown
- 2007-04-10 AT AT07734320T patent/ATE513831T1/de active
- 2007-04-10 PL PL07734320T patent/PL2013208T3/pl unknown
- 2007-04-11 NL NL2000583A patent/NL2000583C2/nl not_active IP Right Cessation
- 2007-04-18 UY UY30291A patent/UY30291A1/es not_active Application Discontinuation
- 2007-04-18 AR ARP070101657A patent/AR060525A1/es not_active Application Discontinuation
- 2007-04-19 GT GT200700035A patent/GT200700035A/es unknown
- 2007-04-19 PE PE2007000483A patent/PE20080192A1/es not_active Application Discontinuation
- 2007-04-20 US US11/737,966 patent/US7902195B2/en not_active Expired - Fee Related
- 2007-04-20 TW TW096114037A patent/TWI337609B/zh not_active IP Right Cessation
- 2007-04-20 DO DO2007000080A patent/DOP2007000080A/es unknown
- 2007-04-20 PA PA20078724201A patent/PA8724201A1/es unknown
- 2007-10-04 UA UAA200812397A patent/UA92637C2/ru unknown
2008
- 2008-09-29 ZA ZA200808283A patent/ZA200808283B/xx unknown
- 2008-09-29 NO NO20084129A patent/NO20084129L/no not_active Application Discontinuation
- 2008-09-30 CR CR10327A patent/CR10327A/es unknown
- 2008-10-07 IL IL194591A patent/IL194591A/en not_active IP Right Cessation
- 2008-10-08 EC EC2008008803A patent/ECSP088803A/es unknown
- 2008-10-17 CU CU20080194A patent/CU23777B7/es active IP Right Grant
- 2008-10-17 TN TNP2008000408A patent/TNSN08408A1/fr unknown
- 2008-10-21 SV SV2008003074A patent/SV2008003074A/es unknown
- 2008-10-21 MA MA31321A patent/MA30352B1/fr unknown
2011
- 2011-07-25 CY CY20111100731T patent/CY1111739T1/el unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020147199A1 (en) *	2000-03-14	2002-10-10	Degenhard Marx	Process for the treatment of erectile dysfunction and product therefor
EP1364950A1 (fr) *	2001-02-26	2003-11-26	Tanabe Seiyaku Co., Ltd.	Derive de pyridopyrimidine ou naphthyridine
WO2006126082A2 (fr) *	2005-05-24	2006-11-30	Pharmacia & Upjohn Company Llc	Pyridine [3,4-b] pyrazinones

Also Published As

Publication number	Publication date
CA2649775A1 (fr)	2007-11-01
JP4436892B2 (ja)	2010-03-24
AP2008004640A0 (en)	2008-10-31
KR101061328B1 (ko)	2011-08-31
EA200801998A1 (ru)	2009-04-28
RS51885B (sr)	2012-02-29
MX2008012456A (es)	2008-10-10
CN101454320A (zh)	2009-06-10
PL2013208T3 (pl)	2011-10-31
IL194591A (en)	2012-07-31
US7902195B2 (en)	2011-03-08
ZA200808283B (en)	2009-11-25
EP2013208B1 (fr)	2011-06-22
MY148583A (en)	2013-04-30
NZ571540A (en)	2010-10-29
KR20080110930A (ko)	2008-12-19
MEP23808A (en)	2010-06-10
TW200808794A (en)	2008-02-16
CA2649775C (fr)	2011-05-31
WO2007122466A1 (fr)	2007-11-01
TWI337609B (en)	2011-02-21
UY30291A1 (es)	2007-11-30
NL2000583A1 (nl)	2007-10-23
NL2000583C2 (nl)	2007-12-14
UA92637C2 (en)	2010-11-25
ES2366239T3 (es)	2011-10-18
CU20080194A7 (es)	2011-03-21
MA30352B1 (fr)	2009-04-01
SV2008003074A (es)	2010-01-12
BRPI0710658A2 (pt)	2011-08-16
NO20084129L (no)	2008-10-29
CN101454320B (zh)	2012-12-19
CY1111739T1 (el)	2015-10-07
HK1133875A1 (en)	2010-04-09
AR060525A1 (es)	2008-06-25
DOP2007000080A (es)	2007-11-15
ECSP088803A (es)	2008-11-27
EA014919B1 (ru)	2011-04-29
SI2013208T1 (sl)	2011-09-30
ATE513831T1 (de)	2011-07-15
US20070249615A1 (en)	2007-10-25
TNSN08408A1 (fr)	2010-04-14
CU23777B7 (es)	2012-02-15
DK2013208T3 (da)	2011-08-15
AU2007242555A1 (en)	2007-11-01
JP2009534368A (ja)	2009-09-24
GT200700035A (es)	2008-02-05
RS20080484A (sr)	2009-07-15
HRP20110539T1 (hr)	2011-08-31
PA8724201A1 (es)	2009-08-26
PE20080192A1 (es)	2008-03-01
AU2007242555B2 (en)	2010-12-16
CR10327A (es)	2008-10-21
EP2013208A1 (fr)	2009-01-14

Publication	Publication Date	Title
AP2408A (en)	2012-05-30	Pyridine[3,4-B]pyrazinones.
IL201973A0 (en)	2010-06-16	3,3-spiroindolinone derivatives
SI2334687T1 (sl)	2012-03-30	Dioksa biciklo oktan triol derivati
EG25264A (en)	2011-11-30	Biphenyl-n-(4-pyridyl) methylsulfonamides.
ZA201001797B (en)	2010-11-24	1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
ZA200805354B (en)	2009-10-28	Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives
IL198250A0 (en)	2009-12-24	Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b
IL195915A0 (en)	2009-09-01	3-amino -imidazo[1,2-a]pyridine derivatives as sglt inhibitors
PL2155712T3 (pl)	2017-02-28	3-(imidazolilo)-pirazolo[3,4-b]pirydyny
DE602007005775D1 (en)	2010-05-20	6-phenyl-1h-imidazoä4, 5-cüpyridin-4-carbonitril-derivate als cathepsin-k- und -s-hemmer
ZA200805756B (en)	2009-04-29	4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivative
IL241548A0 (en)	2015-11-30	Antibacterial quinoline derivatives
EP2202231A4 (fr)	2011-09-28	Dérivé de 2,3-dihydroiminoisoindole
AP2322A (en)	2011-11-18	Antibacterial quinoline derivatives.
PL2099765T3 (pl)	2013-01-31	5-, 6- lub 7-podstawione pochodne 3-aryloizochinolinoaminy jako środki przeciwnowotworowe
IL201444A0 (en)	2010-06-16	New 4, 8 - diphenyl - polyazanaphthalene derivatives
IL188111A0 (en)	2008-03-20	2,5-bis-diamimne [1,4] benzoquinone-derivatives
IL194972A0 (en)	2009-08-03	2-alkoxy-3,4,5-trihydroxy-alkylamide-
IL193483A0 (en)	2009-09-22	4-amino-1,5-substituted 1,5 - dihydro - imidazol -2- ones
PT2010509E (pt)	2014-12-12	Derivados de 3,4-diamino-3-ciclobuteno-1,2-diona como agentes de dilatação do canal de potássio
GB0612774D0 (en)	2006-08-09	Molecular KNEX-structures, more specifically, molecular KNEX-DNA-structures
GB0623583D0 (en)	2007-01-03	Success, success, success
GB0623580D0 (en)	2007-01-03	Success, success, success, success
AU2006902453A0 (en)	2006-05-25	Trolley tracka tm.
HK1143368A (en)	2010-12-31	2-aza-bicyclo-[3.3.0]-octane derivatives